Document is current
Any future updates will be listed below
-
Authors
Bardají, Alfredo https://orcid.org/0000-0003-1900-6974
Peiro, Oscar M. https://orcid.org/0000-0002-8249-8839
Leyva-López, Maria https://orcid.org/0009-0001-5097-2671
Delgado, Juan R. https://orcid.org/0000-0002-8719-9598
Rocamora-Horach, Mar https://orcid.org/0009-0007-0095-1075
Galofré, Montserrat
Fort, Isabel https://orcid.org/0000-0002-6658-3603
Carrasquer, Anna https://orcid.org/0000-0002-4485-8311
Ferreiro, Jose Luis https://orcid.org/0000-0003-1202-9575
- License Information
-
More Information
Article History
Received: 23 November 2024
Accepted: 27 February 2025
First Online: 5 March 2025
Declarations
:
: The study was approved by our Institutional Review Board (Comité Ético de Investigación con Medicamentos del Institut d’Investigació Sanitària Pere Virgili) and conducted in accordance with the Declaration of Helsinki. The approval registry number is CEIM 195/2020. Since the leftover material was acellular, the ethics committee determined that individual patient consent was not required.
: Not applicable.
: The authors declare no competing interests.
